Stroke Research Today is a free monthly online journal that collates and summarizes the latest research about Stroke, including details on treatment, recovery, rehabilitation, signs, symptoms.

Volume 2 (2005), Issue 8 (August)

1. Difference in recognition of right and left hemispheric stroke.
   Lancet, 366(9483): 392-3. [Abstract] [Full-text]
2. Effects of Asian dust storm events on daily stroke admissions in Taipei, Taiwan.
   Environ Res, 99(1): 79-84. [Abstract] [Full-text]
3. Common genetic variants of homocysteine metabolism in ischemic stroke: a case-control study.
   Eur J Neurol, 12(8): 614-8. [Abstract] [Full-text]
4. Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study.
   Thorax, 60(8): 633-8. [Abstract] [Full-text]
5. Poststroke epilepsy: occurrence and predictors--a long-term prospective controlled study (Akershus Stroke Study).
   Epilepsia, 46(8): 1246-51. [Abstract] [Full-text]
6. Predictors of outcome in perinatal arterial stroke: a population-based study.
   Ann Neurol, 58(2): 303-8. [Abstract] [Full-text]
7. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis.
   J Clin Invest, 115(8): 2083-98. [Abstract] [Full-text]
8. Sex differences in cell death.
   Ann Neurol, 58(2): 317-21. [Abstract] [Full-text]
9. Dissociation of sensorimotor deficits after rostral versus caudal lesions in the primary motor cortex hand representation.
   J Neurophysiol, 94(2): 1312-24. [Abstract] [Full-text]
10. Bridging the pharmacokinetics and pharmacodynamics of UK-279,276 across healthy volunteers and stroke patients using a mechanistically based model for target-mediated disposition.
    Pharm Res, 22(8): 1236-46. [Abstract] [Full-text]
11. Risk factors for late stroke after coronary artery bypass grafting.
    J Thorac Cardiovasc Surg, 130(2): 485-90. [Abstract] [Full-text]
12. Circadian variation in stroke onset: identical temporal pattern in ischemic and hemorrhagic events.
    Chronobiol Int, 22(3): 417-53. [Abstract] [Full-text]
13. Rehabilitation education program for stroke (REPS): learning and practice outcomes.
    J Contin Educ Health Prof, 25(2): 105-15. [Abstract] [Full-text]
14. Safety of abciximab administration during PCI of patients with previous stroke.
    J Thromb Thrombolysis, 19(3): 147-53. [Abstract] [Full-text]
15. The related causes in very early morning onset of stroke.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(6): 983-8. [Abstract] [Full-text]
16. The structured assessment of depression in brain-damaged individuals: translation and validation study of the Italian version.
    Neurol Sci, 26(3): 182-4. [Abstract] [Full-text]
17. A risk score predicted coronary heart disease and stroke in a Chinese cohort.
    J Clin Epidemiol, 58(9): 951-8. [Abstract] [Full-text]
18. Cortical reorganization of hand motor function to primary sensory cortex in hemiparetic patients with a primary motor cortex infarct.
    Arch Phys Med Rehabil, 86(8): 1706-8. [Abstract] [Full-text]
19. Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002.
    Arch Phys Med Rehabil, 86(8): 1681-92. [Abstract] [Full-text]
20. The use of a portable muscle tone measurement device to measure the effects of botulinum toxin type a on elbow flexor spasticity.
    Arch Phys Med Rehabil, 86(8): 1655-60. [Abstract] [Full-text]
21. Reliability of biomechanical spasticity measurements at the elbow of people poststroke.
    Arch Phys Med Rehabil, 86(8): 1648-54. [Abstract] [Full-text]
22. The timed up & go test: its reliability and association with lower-limb impairments and locomotor capacities in people with chronic stroke.
    Arch Phys Med Rehabil, 86(8): 1641-7. [Abstract] [Full-text]
23. Test-retest reliability, validity, and sensitivity of the Chedoke arm and hand activity inventory: a new measure of upper-limb function for survivors of stroke.
    Arch Phys Med Rehabil, 86(8): 1616-22. [Abstract] [Full-text]
24. Assessing arm and hand function after stroke: a validity test of the hierarchical scoring system used in the motor assessment scale for stroke.
    Arch Phys Med Rehabil, 86(8): 1609-15. [Abstract] [Full-text]
25. Patients' and relatives' reports of disturbances 9 months after stroke: subjective changes in physical functioning, cognition, emotion, and behavior.
    Arch Phys Med Rehabil, 86(8): 1587-93. [Abstract] [Full-text]
26. The effectiveness of body weight-supported gait training and floor walking in patients with chronic stroke.
    Arch Phys Med Rehabil, 86(8): 1557-64. [Abstract] [Full-text]
27. Reduced ambulatory activity after stroke: the role of balance, gait, and cardiovascular fitness.
    Arch Phys Med Rehabil, 86(8): 1552-6. [Abstract] [Full-text]
28. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients.
    Arch Phys Med Rehabil, 86(8): 1516-20. [Abstract] [Full-text]
29. Brain aromatase expression after experimental stroke: topography and time course.
    J Steroid Biochem Mol Biol, 96(1): 89-91. [Abstract] [Full-text]
30. Supratentorial arterial ischemic stroke following cerebellar tumor resection in two children.
    Pediatr Neurosurg, 41(4): 206-11. [Abstract] [Full-text]
31. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke.
    Arch Intern Med, 165(15): 1743-8. [Abstract] [Full-text]
32. Paroxysmal apnea and vasomotor instability following medullary infarction.
    Arch Neurol, 62(8): 1286-8. [Abstract] [Full-text]
33. Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study.
    Arch Neurol, 62(8): 1232-7. [Abstract] [Full-text]
34. Diffusion-weighted magnetic resonance imaging in symptomatic vertebrobasilar atherosclerosis and dissection.
    Arch Neurol, 62(8): 1228-31. [Abstract] [Full-text]
35. Pure monoparesis: a particular stroke subgroup?
    Arch Neurol, 62(8): 1221-4. [Abstract] [Full-text]
36. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke.
    Arch Neurol, 62(8): 1217-20. [Abstract] [Full-text]
37. The syndrome of combined polar and paramedian thalamic infarction.
    Arch Neurol, 62(8): 1212-6. [Abstract] [Full-text]
38. Therapeutic effects of hydroxysafflor yellow A on focal cerebral ischemic injury in rats and its primary mechanisms.
    J Asian Nat Prod Res, 7(4): 607-13. [Abstract] [Full-text]
39. Impaired corticolingual pathways in patients with or without dysarthria after acute monohemispheric stroke.
    Neurophysiol Clin, 35(2): 73-80. [Abstract] [Full-text]
40. Link between platelet activity and outcomes after an ischemic stroke.
    Cerebrovasc Dis, 20(2): 120-8. [Abstract] [Full-text]
41. The lowest effective intensity of prophylactic anticoagulation for patients with atrial fibrillation.
    Cerebrovasc Dis, 20(2): 114-9. [Abstract] [Full-text]
42. Outcome in patients with stroke associated with internal carotid artery occlusion.
    Cerebrovasc Dis, 20(2): 108-13. [Abstract] [Full-text]
43. Significance of silent infarcts in acute ischemic stroke patients aged 80 years and older.
    Cerebrovasc Dis, 20(2): 92-5. [Abstract] [Full-text]
44. A family support organiser for stroke patients and their carers: a randomised controlled trial.
    Cerebrovasc Dis, 20(2): 85-91. [Abstract] [Full-text]
45. Antithrombotic management after an ischemic stroke in French primary care practice: results from three pooled cross-sectional studies.
    Cerebrovasc Dis, 20(2): 78-84. [Abstract] [Full-text]
46. Prognosis and decision making in severe stroke.
    JAMA, 294(6): 725-33. [Abstract] [Full-text]
47. Assessment of relations between clinical outcome of ischemic stroke and activity of inflammatory processes in the acute phase based on examination of selected parameters.
    Eur Neurol, 53(4): 188-93. [Abstract] [Full-text]
48. Coordination of hemiparetic locomotion after stroke rehabilitation.
    Neurorehabil Neural Repair, 19(3): 250-8. [Abstract] [Full-text]
49. Individual factors in constraint-induced movement therapy after stroke.
    Neurorehabil Neural Repair, 19(3): 238-49. [Abstract] [Full-text]
50. The EXCITE trial: attributes of the Wolf Motor Function Test in patients with subacute stroke.
    Neurorehabil Neural Repair, 19(3): 194-205. [Abstract] [Full-text]
51. Constructing the stroke: sudden-onset narratives of stroke survivors.
    Qual Health Res, 15(7): 928-41. [Abstract] [Full-text]
52. Poor surgical technique in cervical plating leading to vertebral artery injury and brain stem infarction--case report.
    Surg Neurol, 64(3): 221-5. [Abstract] [Full-text]
53. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options.
    Am J Cardiol, 96(4): 53E-59E. [Abstract] [Full-text]
54. Risk factors for cerebrovascular events following fontan palliation in patients with a functional single ventricle.
    Am J Cardiol, 96(4): 587-91. [Abstract] [Full-text]
55. Motor aprosodia due to isolated brainstem stroke in a young woman.
    Acta Neurol Scand, 112(3): 197-8. [Abstract] [Full-text]
56. Endovascular ablation of a temporal lobe epileptogenic focus - a complication of Wada testing.
    Acta Neurol Scand, 112(3): 189-91. [Abstract] [Full-text]
57. How does stroke restrict participation in long-term post-stroke survivors?
    Acta Neurol Scand, 112(3): 157-62. [Abstract] [Full-text]
58. Estradiol prevents the injury-induced decrease of Akt activation and Bad phosphorylation.
    Neurosci Lett, 387(2): 115-9. [Abstract] [Full-text]
59. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
    Neurosci Lett, 387(1): 5-10. [Abstract] [Full-text]
60. The impact of a nurse-led support and education programme for spouses of stroke patients: a randomized controlled trial.
    J Clin Nurs, 14(8): 995-1003. [Abstract] [Full-text]
61. Left frontotemporal hyperperfusion in a patient with post-stroke mania.
    Psychiatry Res, 139(3): 263-7. [Abstract] [Full-text]
62. Contralateral pharyngeal paralysis caused by medial medullary infarction.
    J Neurol Neurosurg Psychiatry, 76(9): 1292-3. [Abstract] [Full-text]
63. Increased platelet count and leucocyte-platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis.
    J Neurol Neurosurg Psychiatry, 76(9): 1249-54. [Abstract] [Full-text]
64. White matter hyperintensities as a predictor of neuropsychological deficits post-stroke.
    J Neurol Neurosurg Psychiatry, 76(9): 1229-33. [Abstract] [Full-text]
65. Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory.
    J Neurol Neurosurg Psychiatry, 76(9): 1222-8. [Abstract] [Full-text]
66. Multimodal effects of available drugs for ischemic stroke.
    Drugs Today (Barc), 41(6): 401-9. [Abstract] [Full-text]
67. Cholestasis in acute stroke: an investigation on its prevalence and etiology.
    Scand J Gastroenterol, 40(7): 862-6. [Abstract] [Full-text]
68. Are some strokes preventable? The potential role of transcranial doppler in transient ischaemic attacks of carotid origin.
    Lancet Neurol, 4(9): 580-6. [Abstract] [Full-text]
69. Relation between migraine and stroke.
    Lancet Neurol, 4(9): 533-42. [Abstract] [Full-text]
70. Survival differences after stroke in a multiethnic population: follow-up study with the South London stroke register.
    BMJ, 331(7514): 431. [Abstract] [Full-text]
71. The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences.
    Scand J Clin Lab Invest Suppl, 240: 143-56. [Abstract] [Full-text]
72. Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke.
    Rheumatology (Oxford), 44(9): 1161-5. [Abstract] [Full-text]
73. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.
    Neurosci Lett, 388(1): 54-9. [Abstract] [Full-text]
74. The reasons for geographic and racial differences in stroke study: objectives and design.
    Neuroepidemiology, 25(3): 135-43. [Abstract] [Full-text]
75. Is the effect of alcohol on risk of stroke confined to highly stressed persons?
    Neuroepidemiology, 25(3): 105-13. [Abstract] [Full-text]
76. A novel method to derive separate gray and white matter cerebral blood flow measures from MR imaging of acute ischemic stroke patients.
    J Cereb Blood Flow Metab, 25(9): 1236-43. [Abstract] [Full-text]
77. Statins and stroke.
    J Cereb Blood Flow Metab, 25(9): 1093-110. [Abstract] [Full-text]
78. Ximelagatran in the clinic: practical management of patients.
    Semin Vasc Med, 5(3): 301-7. [Abstract] [Full-text]
79. Prevention of stroke in patients with atrial fibrillation.
    Semin Vasc Med, 5(3): 285-92. [Abstract] [Full-text]
80. Prenatal stroke in a neonate heterozygous for factor V Leiden mutation.
    Brain Dev, 27(6): 451-4. [Abstract] [Full-text]
81. Molecular mechanisms in the pathogenesis and treatment of acute ischemic stroke.
    J Invest Surg, 18(4): 207-18. [Abstract] [Full-text]
82. Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA).
    Am J Cardiol, 96(5): 39F-44F. [Abstract] [Full-text]
83. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease.
    Am J Cardiol, 96(5): 655-8. [Abstract] [Full-text]
84. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study.
    Brain, 128: 2068-77. [Abstract] [Full-text]
85. Deficits of motion integration and segregation in patients with unilateral extrastriate lesions.
    Brain, 128: 2134-45. [Abstract] [Full-text]
86. Thalamic infarctions cause side-specific suppression of vestibular cortex activations.
    Brain, 128: 2052-67. [Abstract] [Full-text]
87. Cyclosporin A aggravates electroshock-induced convulsions in mice with a transient middle cerebral artery occlusion.
    Cell Mol Neurobiol, 25(5): 923-8. [Abstract] [Full-text]
88. Thrombolysis for stroke in the elderly.
    J Thromb Thrombolysis, 20(1): 5-10. [Abstract] [Full-text]
89. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
    Neuroradiology, 47(8): 616-21. [Abstract] [Full-text]

© 2004-2010 Stroke Research Today. All Rights Reserved.